Akari therapeutics plc (AKTX)
Income statement / TTM
Jun'18Jun'17Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating Expenses:
Research and development costs

0

0

10,185

5,743

5,799

2,983

1,832

2,371

1,616

0

0

0

General and administrative expenses

0

0

9,520

7,754

5,502

1,515

-1,159

-680

303

0

0

0

Excess consideration

-

-

-

-

-

0

-

-

-

0

-

-

Total Operating Expenses

0

0

38,989

32,781

30,584

26,511

0

0

-

0

-

-

Loss from Operations

0

0

-38,989

-32,781

-30,584

-23,781

-672

-1,690

-1,919

0

0

0

Other Income (Expense):
Interest income

0

0

68

51

20

1

0

0

-

0

-

-

Changes in fair value of option and warrant liabilities (loss) gain

0

0

13,089

12,112

11,408

638

0

0

-

0

-

-

Foreign currency exchange gain (loss)

0

0

0

-

-

-

-

-

-

-

-

-

Financing expense

-

-

-

-

-

0

-

-

-

0

-

-

Foreign currency exchange gains/(losses)

-

-

-

101

-

-39

0

0

-

0

-

-

Interest expense

-

-

-

3,049

3,053

3,064

0

0

-

0

-

-

Other expenses

0

0

53

67

44

47

0

0

-

0

-

-

Total Other Income (Expense)

0

0

-12,726

-13,824

-14,732

-25,484

0

0

-

0

-

-

Financial expense (income), net

-

-

-

-

-

-

-

-

-

-

0

0

Loss before Income Taxes

-

-

-

0

-

0

-

0

-

0

0

0

Income Taxes

-

-

-

0

-

0

-

0

-

0

0

0

Net Loss

0

0

-51,716

-46,606

-45,317

-49,528

-1,016

-1,904

-1,947

0

0

0

Other Comprehensive Loss:
Foreign Currency Translation Adjustment

0

0

-283

-106

110

-18

0

0

-

0

-

-

Comprehensive Loss

0

0

-51,999

-46,712

-45,207

-52,014

0

0

-

0

-

-

Other comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

0

-

Comprehensive loss

-

-

-

-

-

-

-

-

-

-

0

-

Loss per common share (basic and diluted)

-0.01

0.00

-0.01

-0.00

0.01

-0.06

-0.00

-0.00

0.06

0.00

-0.04

-0.04

Weighted average common shares (basic and diluted)

1,525,693

1,177,693

1,177,693

1,177,693

1,181,924

781,738

722,345

722,345

163,582

73,370

55,636

49,472